ArticleCureus2026
Prevalence and Predictors of Gastrointestinal Infections Among Patients With Acute Severe Ulcerative Colitis and Those in Remission: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal (GI) infections, common in tropical countries, are likely to precipitate acute exacerbations in patients with ulcerative colitis (UC). However, data are scant. Accordingly, we evaluated GI infections in patients with UC and determined their predictors.
methodsConsecutive patients with acute severe ulcerative colitis (ASUC) and those in remission were evaluated for GI infections by stool microscopy, modified acid-fast stain, culture, and
resultsAmong 158 patients with UC (mean age 35.2 ± 13.0 years; male-to-female ratio 1.3:1; 108 with ASUC and 50 in remission), 79 (50%) had CMV infection (53 detected by RT-PCR alone, one by inclusion bodies, and 25 by both methods). Overall, 92/158 (58.2%) patients had GI infections, of whom 20/158 (12.6%) had multiple infections. CMV infection (70/108 (64.8%) vs. 9/50 (18%); p < 0.001) and overall GI infections (76/108 (70.3%) vs. 16/50 (32%); p < 0.001) were more common in patients with ASUC than in those in remission.
conclusionsGI infections were more common in patients with ASUC than in those in remission, with CMV being the predominant pathogen;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.